Repare Therapeutics Inc
NASDAQ:RPTX 12:33:13 PM EDT
| Market Cap (Intraday) | 1.17B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $32.22 |
| 50-Day MA | $30.89 |
| 200-Day MA | $30.24 |
Repare Therapeutics Inc Stock, NASDAQ:RPTX
7210 Frederick-Banting, Suite 100, Saint-Laurent, Qu�©bec H4S 2A1
Canada
Phone: +1.857.412.7018
Number of Employees: 102
Description
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.